Drug Database
Back to search

United States· US:67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a

Gefitinib

A gefitinib product containing gefitinib, registered in United States by Qilu Pharmaceutical Co., Ltd.. The same ATC class is registered in 13 of our 19 countries.

ATC L01EB01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGefitinibATCL01EB01REGISTER NO.US:67184-0531_8aa73f3…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gefitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gefitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EB01 (gefitinib), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search gefitinib products by name

Gefitinib · ATC L01EB01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gefitinib costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Gefitinib · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$95.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GEFITINIB
Manufacturer
Qilu Pharmaceutical Co., Ltd.
Country
United States (US)
ATC code
L01EB01
ATC class
Gefitinib
Defined daily dose
0.25 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    67184-0531-1
  • ndc11
    67184-0531-2
  • ndc11
    67184-0531-3
  • ndc11
    6718405311
    30 TABLET, COATED in 1 BOTTLE (67184-0531-1)
  • ndc11
    6718405312
    500 TABLET, COATED in 1 BOTTLE (67184-0531-2)
  • ndc11
    6718405313
    3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

414 interactions on record for gefitinib.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gefitinib against other medicinesHow interaction checks work

Gefitinib · interactions on record

414 records

  • 11 severe
  • 193 moderate
  • 5 minor
  • 205 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gefitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gefitinib products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Gefitinib Accord
  • Belgium · Gefitinib Accord, Gefitinib Sandoz
  • Bulgaria · Фромпо
  • Cyprus · Refetib
  • Czechia · Gefitinib Accord
  • Germany · Gefitinib Accord, Gefitinib Genthon
  • Denmark · Gefitinib Accord, Gefitinib Stada
  • Estonia · Gefitinib Auxilia, Gefitinib Norameda
  • Spain · Gefitinib Efg Genthon, Gefitinib Eugia
  • Finland · Gefitinib Accord, Gefitinib Stada
  • France · Gefitinib Arrow, Gefitinib Biogaran
  • United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
  • Greece · Gefitinib Faran, Gefitinib Genepharm
  • Croatia · Gefitinib Pliva, Gefitinib Sandoz
  • Hungary · Gefitinib Genepharm, Gefitinib Onkogen
  • Iceland · Gefitinib Stada, Gefitinib Wh
  • Italy · Gefitinib Medac
  • Liechtenstein · Iressa
  • Lithuania · Gefitinib Norameda
  • Latvia · Gefitinib Norameda
  • Malta · Gefitinib Eugia, Gefitinib Genthon
  • Netherlands · Gefitinib Eugia, Gefitinib Genthon
  • Norway · Gefitinib Stada, Iressa
  • Poland · Gefitinib Accord, Gefitinib Genthon
  • Portugal · Gefitinib Accord, Gefitinib Eugia
  • Romania · Gefitinib Accord, Gefitinib Polisano
  • Sweden · Gefitinib Accord, Gefitinib Stada
  • Slovenia · Phrompo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c52f83ec-c8df-4e1b-8f99-87a96cd98a4d
GET /v1/drugs/c52f83ec-c8df-4e1b-8f99-87a96cd98a4d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "GEFITINIB",
  "productndc": "67184-0531",
  "dosage_form": "TABLET, COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA211591",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about gefitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console